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Abstract
Nowadays, healthcare facilities constantly collect an immense amount of data as
part of their daily-management systems, which include diverse type of information,
such as patient admission details, drugs administered or clinical examinations’
results.
Even though medical research has been traditionally condition-oriented, researchers
oftentimes use similar analysis methodologies, with very little context customization,
making them computationally redundant.
This project proposes an analysis pipeline capable of automatically mine big and
diverse biomedical datasets, and identify potentially interesting patterns in the
data, despite of the medical conditions the data might relate to. Such system is
called an hypotheses engine, as its purpose is to output patterns that seem to be
medically predictive, which we call hypotheses.
HypE’s novelty is two-fold: on one hand, a tailored data processing method was
developed for analyzing inconsistent and chaotic temporal data (i.e. a patient has
laboratory measurements, that usually are only partially repeated over time); and
on the other hand, the hypotheses found are to be outputted in a physician-friendly
way, to allow fast understanding of the patterns found, in case medical intervention
is recommended.
Given HypE’s functionality, results cannot be straightforwardly classified as good
or bad, as certain data subsets might actually not contain any patterns, at all.
However, methodologically, it is to expect that some hypotheses found will be
known medical patterns. Thus, HypE’s outputs are presented and discussed on a
high level, considering no manual check for their medical validity was performed
by medical experts. The prototype implemented was ran on MIMIC-III data and
the results exceeded the initial expectations as they did include common medical
scenarios.
Keywords data mining, electronic health records, temporal data, machine learning,
linear regression , support vector machines, decision trees
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81 Introduction
1.1 Motivation / Health Informatics
Nowadays, healthcare facilities constantly collect an immense amount of data as
part of their daily-management systems. These data are extremely diverse, and may
include patient admission details, drugs administered, laboratory results, among
other type of information.
Computational resources have greatly upgraded, and artificial intelligence is now
living a golden era, being applied to real-world problems like never before, along
with biomedical research that has accordingly been developing heavier data-driven
methods.
Healthcare is, not only about diagnosing and treating illnesses, but also about
preventing them, and biomedical research has been increasingly focusing on the latter,
by crossing knowledge from different fields of science, like genetics and genomics,
with computational resources and techniques developed by applied sciences, such as
bioinformatics. The simultaneous advances of genomic technologies have lead to an
enlargement of biological data available for research, which has surely benefited the
findings.
Accessible biological data (DNA and RNA sequencing data, mass spectrometry
data, etc) combined with computational power, have, to an certain extent, trivialized
massive data analysis, which seems to be progressively making feasible the long-term
belief that medicine is moving towards personalized care [1]. Personalized medicine
(PM) has been frequently described as the tailoring of treatments to the individual
patient, but it is a slightly more extensive concept, consisting on the customization
of medical decisions based on the patient’s genetic profile [2]. For instance, numerous
cancer researches have taken the PM approach, using genomic data to either diagnose
or predict the occurrence of cancer on potential patients [3].
Machine Learning (ML) has greatly contributed for the progress of clinical
medicine, as it has been developing methods that aim at improving the extrac-
tion of knowledge from clinical data available. In fact, ML was initially mainly
focused in disease diagnostics, namely of several cancer types [4], and its focus was
later broaden to disease prediction and prognostics, which is the scope of this thesis.
Health Informatics Technology (HIT) refers to the use of technology to healthcare,
seeking to improve both private and public healthcare, as well as biomedical research
[5]. An example of HIT are clinical decision support systems (CDSS), which analyze
clinical data and subsequently provide users with insights regarding it [6].
Earlier CDSS, and still many of today’s, were designed for some specific context,
where actual medical knowledge was intentionally incorporated within the system
structure [7]. However, considering the significant increase of clinical data being
deliberately collected by biomedical research and healthcare facilities, more recent
CDSS have been developed exclusively upon ML methods, that automatically search
for patterns in clinical data. This work precisely concerns the development of an
automatic analyzer tool for clinical data.
91.2 Research proposal
Although modern medicine repeatedly manages to delay death and making conditions
that were once fatal no longer deadly, there are still an infinite amount of fatal and
non-fatal epidemics that affect millions of people, such as cancer or degenerative
diseases.
The most common approach to clinical studies is condition-based, by limiting
the analysis to a predefined medical condition of interest, for example breast cancer
or Alzheimer’s disease. However, these researches often implement the same analysis’
methodology, with very little context customization, making them, computation wise,
essentially redundant.
Naturally, health care facilities, such as hospitals, have patients suffering from
diverse disorders, and such diversity is as inspiring as it is challenging, from the
research point of view. Inspiring because its variety may provide, for instance, new
insights on correlations across different conditions; challenging because clinical data
is undeniably complicated to work with, specially without deliberately curating it
for a certain purpose.
The aim of this thesis is to develop an illness-independent system that finds poten-
tially interesting medical phenomena in very large biomedical datasets. This system
draws condition-specific scenarios, which are basically nested identified patterns, that
are highly suggestive in identifying patients’ risk of developing complications. More
specifically, these scenarios, exclusively generated from laboratory measurements,
explicitly indicate which variables seem of great importance in predicting the patient
outcome, such as death, the development of new condition, among other possibilities.
Thus, rather than solely pursuing the maximal predictive power of extracted models,
the goal of this system is to unmask understanding of the patient state, by alerting
physicians’ of the likelihood of undesired outcomes.
This work’s contribution is twofold: first, it presents a novel pre-processing tech-
nique to extract relevant data from time-sequential chaotic clinical data, and second,
the system’s output is intended to be physician-friendly, i.e., medical specialists are
presumed to rapidly understand the scenarios being presented, and, if necessary,
intervene accordingly. Figure 1 shows the entire system pipeline and identifies the
mentioned contributions.
Figure 1: High level illustration of the entire system developed, from input to output, with
the work’s contributions highlighted.
This document starts with a background Chapter, where the essential compu-
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tational concepts needed to understand the work are presented. The related work
Chapter then proceeds to summarize the biomedical research that has been developed
following the machine learning approach. Chapter 4 describes the data that was
used in this work, as well as the pre-processing operations that were done before
the analysis itself. Chapter 5 details the entire conceptualized system and its ar-
chitecture, from the feature engineering different steps, to the output generation.
Chapter 6 then proceeds to show some results achieved by the prototype. Chapter 7
discusses the results, while summarizing the entire prototype architecture, as well as
all implementation choices. And finally, Chapter 8 concludes this work.
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2 Computational Background
This section is mainly dedicated to those who are not familiar with what machine
learning (ML) is. It starts with a brief introduction of the concept and the types of
ML used in the biomedical domain. It finalizes with a more detailed explanation of
supervised learning and the methods used in this work.
2.1 From Artificial Intelligence to Machine Learning
Artificial intelligence (AI) is an extensive interdisciplinary field that focuses on
understanding and building intelligence entities. This purposely vague definition was
given by Stuart Russell and Peter Norvig, in what is considered to be the bible book
of modern AI [8] , and its ambiguity is so to include different approaches to different
problems, from the theoretical study of what intelligence actually is, to the study of
how to synthetically build entities that exhibit such “intelligent” behavior.
In computer science, AI can be described as the science and engineering of
making intelligent machines [9], which encompasses the process of both studying and
designing intelligent agents. Intelligent agents are systems that display properties
like autonomy, rationality and reactivity, as an agent perceives its environment, acts
accordingly in order to maximize its chance of achieving its goals, and does it so
without any direct human intervention. Additionally, agents may possess properties
like pro-activeness and social ability, with agents behavior being primarily goal-
oriented and having the ability to interact, or even cooperate, with other agents
[10]. Computationally, AI describes the building of systems that act rationally, not
humanely. This distinction is important, because a system acting humanely would be
indistinguishable from an actual human being, from a cognitive perspective, while a
rational system just means that the system takes the best action to achieve a certain
goal. A simple example of an intelligent agent would be a software-based robot that
vacuums the floor whenever it finds it dirty.
Because intelligence is such a complex concept, AI has broken ground to many
branches of research that focus on different matters, namely knowledge representation,
natural language processing, computer vision, among many others.
Machine learning (ML) has been one of the fastest growing branches of AI.
Simplistically, ML can be defined as the development of systems that have the ability
to extract knowledge from data, i.e., systems that learn and, ideally, such intelligence
is fairly capable of predicting future occurrences of phenomena that have already
happened before. Naturally, different authors define ML differently, some more
mathematically like Alpaydin [11] or more abstractly like Murphy [12], but all of
them share the underlying notation of using past data to foresee patterns.
The ways in which the systems themselves learn are closely related to other fields
of science, namely statistical analysis, pattern recognition or algorithmic optimization.
ML’s main task is to infer from examples, with such inferences being acknowledged
over the identification of patterns in the data. In order to take the most advantage
of available computational power, this process is ideally done through well-designed
and efficient algorithms.
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2.2 Machine Learning
As with most fields of science, different problems motivate the search for different
solutions, which eventually are embodied into different applications. ML is no
different, and health informatics domain mainly adopts mechanisms of supervised
and unsupervised learning.
Supervised learning consists of using labeled data to infer a certain outcome [13].
The idea is that data tends to be identical within use-cases and hence, having labeled
examples should make the process of extracting label-based patterns clearer, which
should theoretically lead to models that better identify that certain behaviour. For
example, if a model is built to estimate the risk of someone having a heart disease
[14], given information like the person’s age, amount of times they reported chest
pain and electrocardiograph results, it should be fairly straightforward to assess, in
the future, if some other person is at risk or not of suffering a heart attack, as Figure
2 illustrates; however, if we give this same model the amount of hours of exercise,
or some other random information as the model’s attributes, the model itself will
not know the difference of the given data’s meaning and thus its output will have no
interpretive meaning.
Figure 2: Example demonstrating how predictive models work. In this case, the input values
belonging to a patient are fed into the model, which outputs if the patient is at risk of having
a heart disease or not. Based on [14].
Unsupervised learning, on the other hand, does not involve label information.
Its goal is mostly about data discovery, without any previous knowledge of trends
or similarities in the data. As such, unsupervised learning is often associated with
data exploration and the quest for data structure insight, also known as descriptive
models. Regularly, unsupervised learning is used to strengthen the researchers’
understanding of the data before actually using it to build predictive models. For
example, researchers may cluster data, as exemplified by Figure 3, to see if patients
who did react to some drug share some specific similarities versus patient who did
not, in order to evaluate which supervised method would be the most appropriate to
build a drug-response estimator.
Considering this work is focused on building predictive models, supervised learning
is further detailed in the next sections.
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Figure 3: Lipidomic analysis of data for schizophrenic patients treated with atypical an-
tipsychotic drugs. Principle component analysis was then applied to these metabolites, and
separation of the groups was visualized with a scatter-plot of the first (PC1) versus the
second (PC2) principal component, where the red squares represent subjects who responded
to drug treatment and blue circles those who did not respond to drug treatment. This picture
is from a study which can be fully read on [15].
2.2.1 Supervised Learning
Machine learning (ML) can be shortly defined as the ability to generalize a task, from
and beyond examples: examples are modeled, and the resulting model is expected to
successfully foresee the task in question when seeing new example data.
Figure 4: Flowchart illustrating the training of a predictive model (top) and the using of a
predictive model (bottom).
In supervised learning (SL), the data being used to build models has been
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previously labeled, i.e, each example is an observation (input) associated with a
label (output), as shown in Figure 4, and the goal is to optimize an input-output
mapping function, which is commonly known as a model. Optimizing such function
is regularly referred to as training the model and it can be simply explained as the
determination of some mathematical function’s parameters; different mathematical
functions mean, therefore, different SL methods.
After the training phase, the predictive model is then ready to be used: given a
new observation, it will output the corresponding label, as it is also shown in Figure
4. When the labels are abstract tags, like cancer or no cancer, we are in presence of
a classification problem; if, on the other hand, the labels are real numbers, like blood
glucose (sugar) values, which normal range goes anywhere from 3.9 to 5.5 mmol/L ,
we are in presence of a regression problem.
Although the general idea of SL is quite simple to understand, there are a few
issues that invariably require scrutiny when actually building a model.
The supervised methods have remarkably evolved and are capable of modeling
complex relationships within the data. Such ability may impress, but unfortunately,
oftentimes it means that algorithms elaborate complex patterns that are unique to
the data being modeled, and not at all reproducible, which may lead to models with
little predictive power.
The whole point of building any predictive model is to encapsulate some knowledge
that is believed to be general enough, within a certain context. For example, if we
build a model for classifying a tumor as benign or cancerous, it is expected to fairly
do it so, for any future tumor data it might be used on.
Overfitting is precisely the inability of a model to maintain the performance
levels achieved in the training phase, when it is fed new data, due to its resulting
model over detailing patterns found in the training data. Thus, such model is likely
to poorly perform on unseen data, even though it appears to successfully classify
training data examples. On the other hand, too simplistic models may not find clear
trends in the data, leading to models that underfit.
Figure 5: Bias-variance trade off: illustration of high bias (left), high variance (right) and
a compromise between them (middle). Picture from [16].
Both these antagonistic characteristics disrupt a model’s ability to accurately
perform, because a model that cannot find evident patterns in the data is just as
useless as one that considers noise as part of the patterns themselves, as it is shown
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in Figure 5. Finding the balance between both extremes is well known in the ML
field as the bias-variance trade-off.
As mentioned, erroneous predictions can be originated by the model’s inability of
finding existent patterns in the data or the ineptitude of adapting to slight variations
around the patterns it learned during training. On other words, the performance of a
model can be decomposed on bias and variance errors: bias refers to the assumptions
that the model encapsulates, whilst variance refers to the sensitivity of the model[17].
Considering that bias relates to the ability of the model to approximate the real
data, high bias leads to underfitting, and is the case where the model failed to learn
clear patterns in the data. For example, modeling a quadratic relationship with a
linear regression will always lead to high bias. On the other hand, variance indicates
the stability of the trained model before new data. Thus, high variance expresses
the model’s inability to generalize the patterns found, and logically tends to increase
with the model’s complexity.
As it should be clear by now, ideally, any predictive model would exhibit low
bias and low variance. However, as that is rarely the case, researchers seek the best
compromise possible, as the center picture in Figure 5 demonstrates.
Given the issues discussed above, it is a standardized practice to test different
models in the data, meaning different parameter values, and chose the one which
displays the most robust performance. A common strategy for model selection is
Cross-Validation (CV) and consists on splitting the data into separate sets, using
different data for training and testing the model[18]: part of the data is used to train
the model, called training set, and the rest of the data is used to assess the predictive
performance of the model on unseen data, known as the test set. Naturally, the
model that displays the better predictive power in the test set is usually the selected
one.
2.3 ML methods
There are numerous classifier algorithms that can be used for building predictive
models [19]. Detailing different algorithms is not the purpose of this project and, thus
the next sections exclusively, and briefly, present the supervised learning algorithms
explicitly used in the final prototype of this work.
2.3.1 Support Vector Machines
Originally, support vector machines (SVM) is a binary classifier, which means that
each input in the data is, or will be, associated to one out of two possible output
classes. Specifically, the idea of SVM is to compute a hyperplane capable of separating
the samples of both classes, with the largest margin possible [20].
As Figure 6 illustrates, the points closest to the hyperplane are called support
vectors, and they basically are the hardest points to classify, as they are the closest
to the separation boundary that is the hyperplane. The distance between support
vectors and the hyperplane is called margin, and SVM performance highly depends
on its ability to maximize this margin.
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Figure 6: Illustration of SVM elements: hyperplane and support vectors.
In most real life classifying problems, however, classes are not linearly separable, as
there is no linear equation that perfectly separates both possible outputs. Therefore,
in science, it is customary for researchers to develop new formulations of known
algorithms to overcome some specific limitations, and SVM has indeed been adapted
for non-linear scenarios.
One technique is to simply relax the original algorithm’s objective function [21],
and shifting the goal to find a reasonable enough separating hyperplane, by balancing
the maximization of the margin whilst minimizing the quantity of misclassifications
[22]. This is achieved through a regulating parameter, C, which value is set by the
user, and it essentially represents the trade off between allowing training errors and
forcing rigid margins. Low values of C allow more training errors while high values
allow the model to select more support vectors, in order to guarantee the correct
classification of the entire training set.
Equation 1 formally details the objective function of SVM, with the mentioned
regulating parameter.
min
⎛⎝∥w∥2 + C∑ ξi
⎞⎠ (1)
, where w represent the weights that are actually learned during the training phase,
ξ the loss function value, and C the regulating parameter.
For further details on SVM and its parameters, we recommend the read of [23].
2.3.2 Kernels
Still regarding the non-linear separability of real-life data, the most common choice
is not to simply relax SVM original constraints. An almost standardized strategy is
to map the data into a higher dimensional space, where the points of each class are
indeed separable, as Figure 7 exemplifies.
A kernel is precisely a function that maps the data to a feature space. Following
[25] notation, a kernel is defined as a function k, that for all x, z ∈ X satisfies:
k(x, z) = ⟨ϕ(x), ϕ(z)⟩ (2)
, where ϕ is the actual mapping from X to an inner product feature space F .
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Figure 7: The kernel trick maps the data into a feature space where the two classes are
linearly separable, through a non-linear mapping function ϕ. Example based on [24].
One major advantage of using kernel functions is the circumvention of expensive
calculations in high dimensional features spaces, by avoiding the need for actually
computing the new feature space, which the classifiers would then use for training,
by implicitly representing them strictly by those space’s inner products.
There are a few kernels that are regularly used in SL problems, from which we
highlight the linear kernel, polynomial kernel and Gaussian kernel. There is no
universal procedure to follow when choosing a kernel function, as it greatly depends
on the data structure [26], hence researchers usually end up empirically selecting
which kernel to use, for a specific problem.
As the Gaussian Kernel (or RBF) was used in this work, a short description is
now presented. Formally, the RBF kernel is defined as
k(x, z) = exp(−γ
x− x′2) (3)
, where γ is the parameter the sets the range of the kernel and it is usually not
manually set, but instead selected by cross-validation. Larger values of γ will lead to
more narrow Gaussian distribution, and smaller values with naturally lead to wider
distribution, as it is shown in Figure 8.
Figure 8: Demonstration of the effect of the parameter gamma, γ, in the RBF kernel, using
SVM algorithm. Data from the breast cancer dataset avaible on Scikit-learn[27].
The review of all kernel functions is out of the scope of this work, and for a deeper
understanding of kernels, we recommend the full read of [25].
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2.3.3 Decision Trees
Decision tree (DT) is a notorious supervised learning algorithm that arranges data in
a comprehensive tree-format, where branches are basically paths that lead to certain
outcomes, represented in the tree extremities, the leafs.
As Figure 9 illustrates, the simplistic representation of DT closely mirrors the
human classification process, where patterns are identified through a sequence of
questions, in which the previous question influences the next one. Such scheme makes
binary DT easy to interpret, even by non-experts, which cannot be said about many
predictive algorithms.
The process of building a decision tree essentially consists on organizing feature
variables on a certain order [28]. The algorithm recursively splits the training data
into smaller subsets, according to certain heuristics and, naturally, finding these
heuristics is one of DT’s biggest challenges.
Figure 9: An example of a simple decision tree that might be used in breast cancer diagnosis
and treatment [29].
Ideally, each heuristic splits the data into homogeneous subsets, which would
ultimately lead to the leaf sets to have a unique outcome class. Unfortunately,
ideal is oftentimes not the case and thus, in order to construct a satisfying DT, the
homogeneity of sets is tracked throughout the building process, and it’s referred to
as impurity. Instinctively, the goal is then to minimize the weighted average of the
impurity of the resulting children nodes [30]. Different impurity measures have been
designed, out of which the Gini index and entropy are the most commonly used by
DT algorithms. The detailing of impurity measures is out of the scope of this thesis,
and for a better understanding of the matter, the full read of [31] is recommended.
An important aspect to consider when building a DT is its final complexity, as
too deep and therefore complicated trees, will have easily overfitted the training data.
The resulting DT are supposed to be general models of patterns and not simply
visualization tools for training data. There are a few approaches to avoid this issue,
namely stopping the splitting of data when no heuristic increases the purity of the
subsets, or to prune some branches by deleting some lower levels of the tree, making
it more generic [30]. For illustrating purposes, Figure 10 shows two examples of
decision trees that were manually pruned, i.e. trees which the last level(s) of nodes
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was purposely discarded. However, the pruning is often given by the complexity
parameter which is fed to the decision tree algorithm, which only outputs the already
pruned tree.
Figure 10: Example of decision trees that were manually pruned, with the horizontal line
indicating at what level. The x/y values inside the nodes indicate the total number of cases
with the condition of interest and the red color indicates the presence of those cases within
the node. For more, the full study can be read at [32].
In addition to the already mentioned simplicity and transparency of resulting
models, the increasing popularity of DT in research can be further explained by its
modeling versatility, dealing with numerical, categorical and/or mixed data, besides
handling data with missing values.
DT have consistently performed beyond expectations, displaying much more
predictive power than initially expected out of such a simple method. Moreover,
more recent approaches of aggregating several DT, such as boosting or random
forests, have yet again over-performed many contemporary and complex predictive
algorithms, and are nowadays considered to be among the SL algorithms with best
predictive performance [33].
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3 Related work
3.1 ML in health care
Health care encompasses many different fields of research, but when talking about
ML, Medical imaging (MI) is clearly one of those fields that has benefited from ML
research, by significantly enhancing already-in-use methods, specially in the area of
diagnosis imaging (DI), and brain function mapping [34].
MI, in general, and DI, in particular, naturally depend on the quality of the
collected images, which has undoubtedly evolved as well, which of course contributed
for the success of different ML methods that were developed and used [35]. This is
of particular relevance considering that the early - and most modern - ML methods
applied in the DI field follow the supervised learning paradigm, which is heavily
dependent on data quantity and quality, as it was described in the previous chapter.
Figure 11: Original description: Illustration of malignant and benign nodules on chest
radiographs together with the likelihood measure of malignancy obtained with a computer-
aided diagnosis (CAD) scheme by use of linear discriminant analysis (LDA) and on artificial
neural net- work (ANN). A computer output above or below 0.50 indicates the likelihood of
malignancy or benignancy, respectively. Picture from [36].
If initially the believe was that computers would end up completely replacing
doctors, the practice has evolved into the the heavy use of computer-aided diagnosis
(CAD), which broadly consists on using a computer output as a second opinion of
a physician’s interpretation of images. Computationally, a CAD system searches
for lesion regions and assesses the likelihood of a disease based on them, for which
different tasks are required, such as image processing for detecting the anomalies and
data processing for classifying those anomalies [36]. Examples of diagnosis research
that incredibly evolved with those are breast, pulmonary and colon cancer researches,
nodules detection [37].
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The ML methods commonly used in CAD were initially mostly linear, such as
linear discriminant analysis, naive Bayes, K-nearest neighbors, with the non-linear
approach of support vector machines and neural networks making a significant impact
in the field [38] .
More recently, deep learning has been heavily researched for the improvement of
many state-of-the-art MI systems, which is not a surprise, considering the impressive
results this approach has achieved throughout different fields, such as image recogni-
tion, natural language processing, speech recognition, self-driving cars, among many
others [39].
The deep learning paradigm allows for the automatic optimization of how data is
represented and consequently used my the algorithms themselves. Particularly in
field of image processing, algorithms like convolutional neural networks (CNN), for
example, have been achieving impressive results, whilst simultaneously simplifying
the training processes[40]. For a more detailed review of how it has been applied in
the MI fields, please read [41–43], as deep learning is outside the scoop of this thesis.
Figure 12: Original description: Some examples of ML achieving state-of-the-art results
in medical imaging applications. From top-left to bottom-right: mammography mass
classification, segmentation of lesions in the brain, leak detection in airway tree segmentation,
diabetic retinopathy classification, prostate segmentation, nodule classification, breast cancer
metastases detection, skin lesion classification, bone suppression. Picture from [40].
Regarding brain function mapping (BIM), and most neuroscience research fields,
in addition to the image processing challenges, and solution approaches already
mentioned, there is the samples versus features dimension issue. For instance, in a
BIM scenario, the collection of data is oftentimes done by recording 128 electrodes,
for a certain period of time. It is easy to understand that in theses cases, one patient’s
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input has a huge dimension, whist the study sample can be on the order of hundreds.
Thus, working around this sample-feature unbalance is always done, and it may
involve spatial, spectral, and temporal pre-processing of the input. Unsupervised
learning algorithms are used for these tasks, of which common choices include Principle
Component Analysis (PCA), Independent Component Analysis (ICA), Non-Gaussian
Component Analysis [44], just to name a few. As unsupervised learning is beyond
the scope of this project, it will not be further detailed.
3.2 ML and clinical data
Clinical data refers to ongoing patient care information, such as electronic health
records that may include demographics, diagnosis, drug prescriptions, laboratory
tests, among other types of information [45]. Besides genomic data, the amount
of clinical data being deliberately collected by biomedical research, and heath care
facilities, have increased significantly in the last few years. Machine Learning (ML)
has greatly contributed for the progress of clinical medicine, as it has been developing
methods that aim at improving the extraction of knowledge from all these available
data, often leading to performance enhancements of previously existing systems. In
fact, ML was initially mainly focused in disease diagnostics, namely of several cancer
types [4], and its focus was later broaden to disease prediction and prognostics, which
is the scope of this thesis. It is worth saying that predictive medicine may deeply
impact, not only physicians’ treatment decisions and patients’ lifestyle choices, but
also health policies, namely regarding diseases awareness and prevention campaigns
or even the implementation of specific treatment policies [46].
For the last couple of decades, numerous ML methods have been used in biomedical
research for disease detection and diagnosis, as well for prediction and prognosis.
Accordingly, feature selection techniques have also vastly evolved, specially regarding
genomic data, of which studies [47–49] are an example of.
Regarding disease prediction and prognosis, the most recurrent research targets
are disease susceptibility, recurrence and survivability, with cancer often being the
condition in the spotlight, representing an impressive slice of predictive biomedical
groundwork. Susceptibility is the likelihood of developing a disease, recurrence
is the prospect of a disease developing once again after its apparent eradication,
and survivability is about predicting life-expectancy, disease progression or disease
sensitivity after the diagnosis [29].
Based on the focus of this work, the study of disease prediction, four major ML
techniques were identified in the literature [50]: artificial neural networks (ANN),
decision trees (DT), support vector machines (SVM) and Bayesian Networks (BN),
with ANN and DT undoubtedly being among the first algorithms applied to biomedical
research.
The concept of ANN is based on the human brain functionality, and they are
frequently used in predictive modeling, as they have been consistently shown to
fairly capture highly complex patterns in the data. ANN have been used to predict
the occurrences of various diseases, such as cardiovascular diseases, endless types of
cancer, among others [51]. On the other hand, DT are a rule-based approach that
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progressively splits the data according to identified trends, consequently generating
models that are easy to understand. An overview of medical applications using DT
can be consulted in [52].
More recently, SVM and BN have been applied to disease predictive modeling,
having often achieved impressive results. In short, SVM takes high-dimensional data
and attempts to find a hyperplane that separates the different classes, with as large
a margin as possible. SVM have been successfully used with both genomic [53] and
clinical data [54], having lead it to be one the favorite algorithms to consider when
building predictive models, in medical research as well as on other contexts.
A BN is a probabilistic graphical model that expresses variables and their de-
pendencies, via a directed acyclic graph. They have become increasingly popular
mainly due to their demonstrated ability to handle the uncertain knowledge involved
in establishing diagnoses of a disease [55]. Several real-world applications of BN in
bio-medicine are reviewed in [56].
3.3 Longitudinal cohort studies
Figure 13: Illustration of the concept of cohort data. Left picture: description of one
sample, the unit of cohort data. Example of both clinical and genomic data. Right picture:
illustration of cohort data.
The choice of method(s) to use in a certain study is naturally influenced by the
structure of the data. Cohort data refers to samples data and, in the context of this
work, it may refers to clinical, genomic or combined data, as Figure 13 illustrates.
The majority of cohort studies use two-dimensional data, meaning that each patient
is represented by one sample. However, high-dimensional cohort data has been
progressively more used, with each patient being represented by several observations,
usually repeated measurements of the same variables, over a certain time period.
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If the samples are collected over a long period of time, we are in presence of a
longitudinal cohort study.
Cohort data, given its time-series nature, is likely to contain subtle patterns that
may be quite informative in respect to patients physiological state and, therefore,
their long-term outcome. There are two main types of analysis implemented on
cohort studies: survival analysis or the already mentioned predictive analysis.
Survival analysis regards a collection of statistical procedures for analysing data
where the outcome variable is the time until the occurrence of a certain event [57],
that could be either death, divorce, market crash, or any other. In the clinical context,
survival analysis is of great interest, as it gives important insights into the evolution
or regression of patients’ state throughout time, for example, if treatment is indeed
being effective or not [58].
Straightforward predictive modeling is, nonetheless, still extensively used with
high-dimensional cohort data, either by analysing data in its time sequence format,
or by transforming it into two-dimensional data through either feature selection or
feature extraction techniques. Time-series classification methods have, as a result,
been increasingly integrated into longitudinal cohort studies and their approach is
inherently related to similarity metrics. There have been studies published where
this methods have proven surprisingly effective, such as [59]. Bolder approaches have
found ways to have standard ML algorithms, DTs for instance, dealing with specific
constrains, such as time series data [60].
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4 Clinical Data
Healthcare facilities regularly save different types of patient information, from personal
demographic details, like age and gender, to specifics about patients’ past and ongoing
medical care, such as medical history, diagnosis or treatments. Nowadays, all this
data is naturally digital and is commonly referred to as electronic health records
(EHR) [45]. An EHR includes different types of data, that are frequently being
collected from different sources and used for diverse purposes. For instance, personal
details may be used mainly by administrative staff, while laboratory results are
presumably primarily used by healthcare professionals, like physicians, nurses or
pharmacologists.
In biomedical science, clinical trials have been the standard approach for collecting
medical data, on which studies are subsequently based upon. However, this approach
has always had the inconvenience of being too time consuming, expensive and
condition specific, as a result of following a group of subjects throughout a certain
period of time (that could go from a couple of weeks to a couple of years), oftentimes
for a very specific research question [61, 62]. Plus, several ethical questions have been
raised regarding clinical trials [63]. All these reasons have made EHR very popular
in biomedical research, even though it only allows for retrospective clinical studies,
which is a paradigm shift from the classic prospective clinical studies. Healthcare
facilities collect EHR anyway as part of their management systems, making them
a cheap source of extremely diverse data, especially considering its volume, both
patients and measurements wise.
When using EHR as the source of clinical data, there is the additional challenge
of the data sources’ heterogeneity [64], with different measurements being collected
separately and not at all integrated in the database. For example, blood laboratory
tests and monitoring devices of vital signs are rarely annotated as possibly medically
associated, data-wise. Moreover, there is also the heterogeneity of the type of
measurements that could be either numerical, categorical, free-text, or some other
type. Researchers must also be attentive to the possibility of erroneous data, missing
data and be particularly cautious when using imprecise data, such as data with
unknown labels or ambiguous manual annotations. For a more detailed analysis of
the challenges of collecting and working with clinical data, we highly recommend the
full read of [65].
4.1 MIMIC-III Database
This project was developed using the freely available Medical Information Mart of
Intensive Care (MIMIC) database as a source of clinical data, specifically the latest
release - MIMIC-III, which is a large, single-center database that includes diverse
information regarding patients admitted to critical care in Beth Israel Deaconess
Medical Center, in Boston (USA), between 2001 and 2012 [66].
It is worth mentioning that MIMIC is, of course, fully documented [67], and it
has been extensively used on biomedical research, as a credible source of clinical data,
for studying diverse matters such as the effect of age and other clinical circumstances
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on the outcome of red blood cell transfusion in critically ill patients [68] or the trends
in severity of illness on ICU admission and mortality among the elderly [69], just to
name a few examples.
First and foremost, working with MIMIC solved the complication of integrating
different sources of medical data into one single system, which would have been a
difficult first step of data pre-processing, with the aggravating potential of influencing
the study’s results, possibly even invalidating them. Secondly, the actual variety of
data per patient, which is summarized in Figure 14, from time-stamped physiologi-
cal measurements, to physicians’ free-text observations, among many others, is of
immense value, providing the researchers with an unparalleled multi-dimensional
perspective that was not frequently possible with data collected from clinical trials,
where usually only few specific measurements that researchers believed to be of
interest would be considered. Beyond the wide variety of information, the volume
of data available also provides the possibility of using novel data-driven methods
of machine learning on a field that has traditionally had limited amounts of data
to work with, which can lead to new findings or even deepen our understanding of
certain medical conditions, and therefore minimize their mortality rate.
Figure 14: Types of data available in MIMIC database[66].
As it is based on EHR, MIMIC essentially consists on raw medical data, which is
of particular interest, considering that many cohort databases available for research
have been through unclear stages of data preprocessing. However, the fact that the
data is from intensive care units raises some concerns, mainly because these are
the most critically ill patients, and being in such health condition may make the
data noisier than expected, or not at all appropriate for extrapolating conclusions to
non-critical patients.
4.2 Data Structure
Due to the limited duration of this project, not all available data was used in our
system. This project solely used numerical laboratory measurements, along with
the associated diagnosis information and patients’ demographic details, of which a
sample is shown in Figure 15.
The table referring to patient demographics, the "patient’s table", consists of
five variables: the subject unique identifier number, gender, date of birth, date of
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Figure 15: MIMIC’s data tables and how they are connected.
death and a status flag that indicates whether or not the patient has died, both
within or outside the hospital. The diagnosis table lists all diagnosis the patient
was associated with, for billing purposes at the end of the hospital stay, and they
follow the ICD-9 (International classification of diseases) codes [70]. Lastly, the
laboratory measurement table is the main source of clinical content. It has around 25
million entries, and consists of all measurements conducted, for each patient, of any
item, along with the corresponding timestamp. It is worth noting that all MIMIC
information regarding dates was shifted years into the future values, fulfilling the
required data privacy regulations.
Besides the above data tables, we used the diagnosis and laboratory items’
dictionary tables, shown in Figure 16, exclusively for consulting the human-readable
labels corresponding to the numeric codes.
The reason for selecting a subset of all available data in MIMIC was two-fold.
First, the scope of this thesis automatically excluded data in formats like free-text
or imaging data, due to the fact that such approach would require natural language
and image processing techniques to convert the data to the appropriate input format
envisaged for our system. Secondly, once the data was circumscribed to numerical
and categorical measurement values, the decision to drop the latter was mainly
due to the fact that numerical data is more versatile to work with, considering
the experimental environment where existent methods were used to explore and
experiment on data. Therefore, having more diversity of algorithms to understand
the data was an important advantage in the early stages of development.
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Figure 16: MIMIC’s dictionary tables.
4.3 Clinical Laboratory Measurements
As mentioned before, this work deliberately considers the laboratory measurements
of patients the only source of data. This subsection describes such MIMIC subset,
as a context for the system development, which is described in the next chapters.
The considered laboratory dataset reports the measurements of over forty-six
thousand patients, from neonatal to elderly patients. However, considering the
research goal to automatically mine the clinical dataset, it was a conscious decision
to consider only patients from the age of ten onward, as well as excluding patients
over ninety years old. Such compromise was achieved considering that both these
groups of patients are potentially admitted into ICU given some very specific medical
conditions. For instance, premature newborns have an even higher risk of survival
given their physiological development might not be complete, or very old people’s
recovery might be less likely given their advanced age. Thus, only patients from 10
to 89 years old were considered, which we catalogue as adult patients, and Figure??
shows this dataset age distribution, as well as the correspondent survival quota.
Figure 17: Generic metrics of MIMIC subset considered in this work, before any pre-
processing.
Figure 17 summarizes the subset of data considered the system’s database,
i.e., MIMIC data after excluding neonatal and advance elderly patients’ related
information. From this point on, such subset will be simply refer to as data, as it all
the data available to the system that was developed.
Figure 18 illustrates the gender distribution of the data, as well as the survival
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quota, showing that the survival quota tend to decrease with age, which makes
theoretical sense, considering older people are naturally more likely to succumb to
a serious condition than younger people, even considering that intensive care units
always involve serious life threatening conditions.
Figure 18: Left picture: Age distribution of adult patients at time of ICU admission[67].
Right picture: Gender distribution and correspondent survival quota of the adult patients
admitted into the ICU.
4.4 Data Pre-processing
MIMIC is periodically maintained and updated, which means that most common
"contamination" issues of cohort data sets have been solved. For instance, there are
very few missing values or imprecise entries. Nevertheless, is usually recommended
to inspect the data for such issues anyway, to avoid later set backs. Thus, the
pre-processing phase was considerably minimalist.
On the subject of data quality, three simple condition scenarios were used to
identify which data entries were invalid and hence to be excluded from further analysis.
Each scenario has targeted a different use-case of invalidation and here are their brief
descriptions: (1) missing data, specifically measurement data with no item code or
no value; (2) ambiguous data, meaning multiple measurement entries for the same
patient, same item, at the same time, with different values; (3) imprecise data, as in
unlabeled data entries, such as diagnosis with no valid code.
Around sixteen thousand entries were identified and excluded from further analysis,
most of which were duplicate entries, making the final processed data numbers shown
in Figure 17 unchanged. Even though it may look like a lot of entries excluded,
considering the abundance of data available, not much time was spent investigating
these dropped entries.
In other respects, the binary variable "FLAG" was initially only filled with one
possible value, which makes sense in terms of data storage, but for development
purposes, mainly for visualization, this variable was populated with the missing
attribute, as it is shown bellow in Figure 19.
The final step of pre-processing concerned the temporal nature of measurement
data. As it was mentioned before, and it is shown in figures above, each measurement
entry has a time-stamp, represented by the "CHARTTIME" variable, which indicates
the date and time of the measurement. However, such detail overshadows the
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Figure 19: Pre-processing of binary variable "FLAG".
relevant information when the database has entries collected over 10 years. To deal
with this phenomenon, all laboratory entries were serialized within the context of a
patient, meaning that entries would now have a serial number representative of the
ith time that item was measured on that patient. For a better understanding of the
serialization, Figure 20 illustrates an example.
Considering this project aims at developing a non-condition-specific data mining
tool, this serialization provided the ideal abstraction of the standard timestamps. In
this new format, all patient’s measurement data are now mapped into an universal
chronological scale, which provided an orderly structure for studying the progression of
any variable, which is tremendously useful when applying machine learning techniques.
Another aspect of serialization that is worth mentioning is the fact that it does
not take into consideration different ICU stays. Thus, after serialization, each patient
has an unique sequence of measurements, different for every laboratory item. The
belief is that sequential ICU stays may be related, as the human body does not
restart after getting better (or even cured), and so, considering all measurements
throughout time was an approach that allowed the system to abstract from ICU
stays bureaucratic details, such dates and duration, making it focus and use or ignore
the measurement values, which is exactly what we want to mine.
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Figure 20: An example illustrating the serialization of measurements timestamps.
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5 HypE System
As stated before, the aim of this project is to design and implement an illness-
independent system that mines biomedical datasets for potentially interesting medical
phenomena. From this point on, for simplicity, such findings will be referred to as
hypotheses. Thus, our system can be described as an hypothesis extractor engine
(HypE).
HypE was envisaged to be a global data mining tool capable of examine any
medical data, but as a proof of concept, it was implemented to firstly require some
selection of data, which we call data of interest, and it simply consists on the data
relative of a certain scenario to examine. As such, Hype can be seen as encompassing
four distinct phases: selection of data of interest, feature extraction, predictive
modeling and hypothesis embodiment. Each phase is henceforth detailed. After
selecting the data of interest, the first analysis phase concerns feature extraction,
which is responsible for transforming the data into a higher-dimensional format,
where each entry is represented by several new variables, called features. Next, the
newly computed feature data is used to build a predictive model and if the resulting
model shows a reasonable predictive performance, it is assumed as indicative of the
data containing potentially interesting patterns, in which case the feature data is
then translated into an user-friendly hypothesis format.
It is worth clarifying that the contribution of this work is in the pipeline itself,
meaning that for each phase, different methods than those used in the implemented
prototype can be used, without compromising HypE’s premises or purposes.
Figure 21 summarizes the entire pipeline, and the following sections specify all
phases in greater detail, as well as present and justify the methodological choices
used in the prototype used as base for this work.
Figure 21: Schema of the HYPE pipeline. Starting with MIMIC database, which is the
data source of the system, showing the main three steps of data processing and analysis, up
until the output of the hypothesis found.
5.1 Selection of Data
Considering the complex nature of clinical data, detailed in the previous chapter, one
way to facilitate its computational analysis, whilst guaranteeing the requirements for
valid results, is to restrain each analysis to a consistent scenario. For example, for
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investigating if patients diagnosed with diabetes type 2 are more likely to die when
admitted into the ICU, HypE would first select all patients with that diagnosis, along
with all their medical data, and use only this selection of data in the next phases of
the analysis’ pipeline. The resulting data of this selection is the data of interest.
The data of interest is, then, a conceptual structure that contains patients with a
certain medical condition, for example, patients that share a diabetes type 2 diagnosis,
associated with a binary output variable being analyzed that could be, for example,
survival outcome of those patients, in addition to all their clinical measurements. As
of the time of this document, the system implementation can only assume binary
outcome values.
Associating patients to a binary label is a straightforward way to abstractly
represent any outcome of interest, from dead or alive, to diagnose A or B, or any
other dichotomy. Therefore, this abstraction allows HypE to inspect any pattern
of interest, regardless of possible medical specifics of the scenario in the spotlight.
Within HypE’s context, the data of interest can be simply referred to as data.
Figure 22: Illustration of the selection of data before getting analyzed. The green box
accentuates the data that is actually analyzed for patterns.
Figure 22 illustrates how the data subsets are build out of the all data available.
The green box highlights the data subset ready to the analyzed by the system. In
case it is not clear, this dataset structure is the same as previously shown in Figure
15, only now, each laboratory measurement is also associated with the outcome being
analyzed.
Finally, it is important to mention the requirements that the system has regarding
the selection of data. As of now, system has two requirements to accept a subset as
valid for analysis, which concern subset size and outcome balance.
Considering the data will be analyzed for its predictive power in the following
phase of the pipeline, the size of that data is naturally of importance, as if we have a
scenario containing data referring to only 8 patients, the sample size is definitely not
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big enough to be tested for predictive power. For this same reason, even in cases
where the size of the data subset is enough, it is essential to check if there are enough
samples representing both outcomes, as if we have a subset of 300 patients’ data,
but only 2 of them represent one of the outcomes, any results from modeling the
data would be not credible and thus not valid for interpretation.
In the prototype implemented, both values regarding these requirements were
previously defined and hard-coded. Therefore, as of now, the data of interest has to
include the minimum sample size of 100 patients, and regarding the outcome balance,
it was defined that both outcomes must have at least a third of all samples. For
instance, if the subset included 100 patients, both outcomes need to have at least 33
samples. If any of these criteria is not met, the system does not proceed with the
analysis.
5.2 Feature Engineering
Oftentimes, datasets are a collection of variables, commonly referred to as features,
that have clear distinguishable meanings. As it is shown in Figure 15, in the previous
chapter, the data has features like patient id, item id, value or timestamp. However,
such structure might not be the most appropriate for computationally analyzing the
data, which is precisely the purpose of feature engineering.
Feature engineering is a generic term that refers to all methods involved into
assembling data with the, as optimal as possible, format for computational analysis,
and the resulting data is commonly referred to as feature data. The processing of
data may include methods for features extraction, or selection, among other type of
restructure. Although feature extraction and selection are often referring to the same
operation, in this document, the first refers to the computation of new variables,
from the original available ones, while the latter refers to choosing some of those
out of all the newly computed variables. For example, a dataset has 10 original
variables, out of which 300 new variables are computed, and then, only 52 of those
are considered to analysis, thus being the feature data.
It is important to clarify that the feature data is, just as the original laboratory
data, organized by variables, but the difference is that in the former case, those
variables to not always have to have any human-understandable meaning, as they
can be as abstract as the correlation between two variables in a high-dimensional
space, for example.
Considering the structure of the data available, as well as the output desired
of the system, it was evident that some data processing had to be done. When
observing the data, it was noticeable that different items were measured at different
rates, and with different periodicity. Medically, measurement rate is influenced by
several factors that are closely related to the specifics of a patient medical condition,
which is why clinical data is usually so irregular, with many patients outlying out of
measurements frequency trends.
Figure 23 shows an example of how the data used for analysis can be visualized,
where each line represents one patient. Naturally, given the sequential nature of the
data, it is always possible to attempt to manually look for possible patterns that
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Figure 23: Visualization of two exemplifying laboratory items as a time-series, for the
entire cohort of patients with records for those items.
distinguish outcomes. However, as it shown, it can be messy and unproductive.
The inconsistent nature of clinical data, in addition to the diversity of laboratory
items available, complicated the feature engineering, once there was no simple
approach to assemble our feature data. Straightforward strategies, such as considering
as features all (item, ithmeasurement) pairs, were simply not feasible considering
the result would be a wide and sparse feature set. Having a set with many features is
not a problem, on its own, and it is actually an objective of ours, but these features
would be mostly empty anyway, with most patients having a different set of items,
and frequency, for which they were measured.
Looking ahead, the resulting feature data would be then used to build a predictive
model. Hence, our goal was to get a dense feature dataset, while still extracting as
many features as possible.
In order to overcome the challenges mentioned above, HypE’s feature engineering
includes two consecutive methods for extracting and subsequently selecting new
features, after restricting the measurements to a certain time range. Regarding the
first mentioned segment, which we titled of gradient analysis, we have developed our
own algorithm that computes a dense set of features, and then, we use a statistical
approach for dropping the newly features that seem to be of no relevance for the
posterior analysis.
Figure 24 illustrates the whole feature engineering process, and each step with be
detailed in the following subsections.
5.2.1 Time-restriction
The previous chapter explained a time serialization operation that the system performs
while pre-processing the data. Although such operation facilitates computational
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Figure 24: Feature engineering phases: time-restriction approach, followed by the gradient
analysis. After, the data is in the appropriate format for analysis, which we designate by
feature data.
analysis, there are some cautions that must be taken because of it.
MIMIC’s database was collected over a decade, which means that is likely that
some patients have been admitted into an ICU more than once, over the course of
that decade. This is a problem for two reasons: (1) admissions with years apart
make it more likely that different medical reasons were the cause of those admissions;
and (2) even if the patient is admitted for the same medical complications, abnormal
measurements are likely to lead to medical intervention right away and so, after
serialization, it is impossible to know if a certain measurement is constantly showing
abnormal values or if some values are just distant in time in the original timestamps.
Few occurrences would be enough to contaminate some outputs of the system and
hence, in order to avoid those pitfalls, and considering the prototype implemented
solely focus on survival as the outcome variable in question, the strategy is then
to restrict the clinical data being analyzed to laboratory measurements showing a
timestamp within a month of the outcome. For instance, if a patient is registered
as dead, the date-of-death (DOD) is considered to be time point zero, and all
measurements taken in the last month are considered; if the patient is not registered
as dead, the last day of the ICU stay is considered time point zero. However, after
the restriction, the time points are inverted, so that the outcome corresponds to time
point 10.
If the outcomes to be analyzed are different that survival status, the time point
zero is simply adapted. For instance, if we want to see if it is possible to predict if
diabetic patients are likely to be diagnosed with pancreatic cancer, the system can
just assume the latter diagnostic date to be time point zero.
In addiction to the month restriction, the system makes use of the last 10
measurements, within that month range. It is set up as so due to the conviction
that the closer to the outcome, the more differences must be identifiable within the
outcomes. In the prototype implemented, both the month time window and the the
amount of measurements considered are hyper-parameters of the system, and thus
can be changed by the user at any given time.
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5.2.2 Feature Extraction
HypE’s prototype was implemented to search for simple patterns, specifically the
increase, decrease or stability of the value of any item, that seemed predictive of a
certain outcome.
Accordingly, we have developed a method for extracting new features that essen-
tially consists on representing a variation of an item as a single value, by computing
the slope of the item variance, between two given time points. This process is
repeated for every two time points combination, following a sliding window approach,
and for every item, for each patient. In the resulting feature set, each patient is then
represented as a group of variables that express how much items values have changed
overtime. Figure 25 shows the extraction of feature method.
Figure 25: Illustration of the sliding window approach for extracting features: for each two
time-points, the gradient is computed, as registered as one feature.
It is worth recalling that in the data of interest, each patient is associated with a
binary label, which represents one out of two possible outcomes being analyzed. For
example, the label can express dying or not at the ICU. Therefore, having the new
variables computed, the feature data has now a two-dimensional format, where each
patient is represented as a collection of newly computed variables, and is identified
with the corresponding outcome label.
5.2.3 Feature Selection
When data sets have a substantial amount of features, it is frequent that not all
of them express relevant information. In order to minimize the chance of certain
features polluting the overall appliance of the set, it is common to submit feature
sets to some selection method, where they are subjected to a validation analysis, and
naturally, only the ones that seem suggestive of being somewhat interesting are kept
for the final feature set.
In HypE, the validation analysis of features is a purely statistical mechanism.
Each feature is mapped into two cumulative distribution functions (CDF), each
one representing a label of interest data, and a feature is considered relevant if the
difference between those two distributions is statistically significant.
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Figure 26: Left picture: the illustration distribution of the data of a certain item, were
all patients are considered. Right picture: the representation of the same data as the left
picture, but as a cumulative distribution function (CDF). The line on the plot represents
the maximum point in which the distributions are different, computed by the Kolmogorov-
Smirnov test. Color code: red represents the data of outcome variable “alive” and by
opposition, the blue represents the data of outcome “dead”.
The assessment of significance is achieved through a two-sample Kolmogorov-
Smirnov (KS) test statistic. In short, two-sample KS test is commonly used for
comparing two continuous populations [71], in our case, two CDFs. If there are
enough discrepancies between the samples, they are assumed to be have drawn from
different distributions, in which case the feature being analyzed is considered relevant.
The presumption is that if the label-based CDFs are different enough, it is highly
suggestive that mining algorithms might be able to identify label-unique patterns
within that particular feature, making it an important feature to preserve for the
final feature set, as HypE’s intent is precisely to find trends, within items, that might
be predictive of patients’ aftermath.
After the selection of relevant features, each patient is then represented by a
smaller amount of features than before, but all of which seem greatly informative,
finalizing the processing of the feature data.
5.3 Predictive Modeling
The purpose of this stage is to inspect the data for its predictive power. The
conviction is that the model performance is indicative of the presence, or not, of
distinct patterns that seem indeed associated to the patient’s outcome. Hence, if
the model exhibits promising forecasts, the data is flagged as containing interesting
phenomena, and is afterwards subjected to the hypothesis extraction process, where
these phenomena are encapsulated into an hypothesis. This section details the
modeling process, as well as how the assessment of interest is achieved.
First of all, bear in mind that different predictive algorithms have different data
format requirements, especially regarding missing values. Some algorithms have
not been designed for dealing with be absence of data appropriately, which may
obstruct the resulting model in unpredictable or even non-understandable ways. For
example, considering missing values as zero is a simple yet brutal mistake that might
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make models highly untrustworthy because they will not distinguish those cases from
features originally with the actual value zero, misleading the training of the model.
In HypE’s prototype, the method selected for the predicting modeling was support
vector machines (SVM), which in its original implementation does not support missing
values [72]. Thus, in order to guarantee more authentic results, the data to be used for
training the model should be complete, i.e., the data should not have missing values.
For that reason, the system does include an extra-step for discarding observations
with missing values, which is detailed in the next sub-section.
5.3.1 Missing values
After the extraction and selection of features, processes described in prior sections,
the resulting data is quite dense, as Figure 27 simplifies, meaning that most patients
do have values for most features. However, a completely full dataset is, indeed,
rare, which makes sense given the nature of clinical data, where the follow up of
measurements is directly related to patients specific clinical status, and not necessarily
connected to the outcome label being analyzed within a specific condition of interest.
Figure 27: An example of feature data: each line is a subject, represented by several features
values.
In the interest of removing the missing values from the feature data, HypE has
its own method for sub-selecting a full dataset, out of the original feature data, and
that method was developed with the intent of minimizing the amount of data to be
discarded. A simple approach to the problem would have been to drop all patients
(or features) that displayed missing information, but such solution would often result
in small complete datasets, as Figure 28 illustrates, occasionally so small that not
enough data was available to properly train the predictive model.
Moreover, when looking at the missing values, it was noticeable that some features
usually contain much more missing values than others, which means there are groups
of patients that were clearly not measured for some items. For example, a possible
explanation might be that such features relate to some laboratory item that was
extraordinarily followed up for some patients, for some medical reason. Thus, after
exploring the distribution of missing values, for several datasets of interest, it seemed
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Figure 28: Heapmap of missing values (blue colour), and the corresponding complete sub-
selection of data, following the naive approach of excluding all patients with any missing
values.
logical to systematically discard features that carry a significant quota of mission
values. In the current prototype, all features that have more than 30% of missing
values were automatically discarded.
Figure 29: Heapmap of missing values (blue colour), and the corresponding complete sub-
selection of data, following the Hype’s approach of firstly discard features with a high quota
of missing values.
Figure 29 illustrates that starting by excluding features with a considerable
amount of missing values, and only then excluding patients with missing values,
results in a bigger complete dataset, as intended. For disclosure, it is important to
highlight that this cutting-off approach was only feasible due to the abundance of
data available on MIMIC, and of course considering HypE was designed to be used
on big biomedical databases. If this would have not been the case, in scenarios with
limited data available, non discarding methods would have been considered, such as
imputation [73], where missing values are replaced by some estimates.
5.3.2 Support Vector Machines
As mentioned before, SVM was the algorithm chosen for modeling the clinical data.
Briefly recapping, SVM is an algorithm that finds a boundary, called hyperplane, in
the parameter space that better separates the label cases [74], corresponding, in this
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project, to examples like "died" or "survived". Computationally, mapping all data
points into a higher-dimensional space can be heavy if the data is big enough, which
is why SVM is commonly paired up with a kernel function that computes the dot
products of data points directly in the high-dimensional space, based on which the
hyperplane is then determined. For a more detailed explanation of SVM and kernels,
revisit chapter 2.
As previously discussed, SVM performance is heavily influenced by the choice of
its parameter values, as well by the choice of kernels functions [75]. Regarding the
latter issue, there is no scientific rule-of-thumb to follow when deciding which kernel
to use because it greatly depends upon the data itself, structure-wise [76], which is
why often several kernel functions are tested for the specific data in analysis.
In the implemented prototype, SVM uses the Gaussian kernel (or Radial Basis
Function kernel), which is considered, by the scientific community, a good default
choice for continuous data [77]. In this set up, two non-trainable parameters, also
known as hyperparameters, are computed, C and σ. C parameter controls the
complexity of the boundary between support vectors and sigma is a smoothing
parameter. As these values are not changed during training, they can be either
specified directly by the user, or they can be estimated, through a grid search [78],
in which case the values that have lead to better performance are the ones chosen.
Figure 30: Grid search example: how the values of C and gamma parameters influence the
model performance, specifically illustration of SVM with RBF kernel. Iris dataset, using
the Scikit-learn tool [79].
In HypE, the system uses leave one-out cross validation (LOOCV) for estimating
the best parameter values to use to train the model. Briefly, LOOCV consists on
picking one single case as the test set, at a time, and doing it so that every point
is used once as a test case. Although LOOCV might be time expensive, which
increased with the data size, it is a cross validation technique often used when the
data available is limited. The reason for that is that by leaving one point out, at
each iteration, it is ensured that the training set is constantly representative of the
whole dataset [80].
One of the biggest advantages of LOOCV is that it is an unbiased estimate of the
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generalization error. However, the fact that almost all data is used for training, in all
iterations, leads to higher variance too, due to the overlap between training sets [81].
Given the fact that diverse subsets are analyzed in the system, it made theoretical
sense to use the grid search strategy for computing the “best” parameters, for each
dataset.
In practice, it was only specified a range of values of the parameter C, and for
each, a σ estimation value was analytically derived. This choice was suggested by
the default implementation of the machine learning tool used, and it was kept due
to be considered a good solution to control the time expense of the cross validation
operation, in case the datasets are to be sizable. Thus, the range values considered
were:
• Parameter C: range [0.25, 0.50, 1.00, 2.00, 4.00, 8.00, 16.00, 32.00, 64.00]
After the first pass on the data which aims at finding the best values for the
hyperparameters, then a second pass is done by the SVM algorithm, which then
models the data with the freshly chosen values of the C and σ parameters.
5.3.3 Model evaluation
In order to assess the potential predictive power of the dataset being analyzed, HypE
models the data five different times and compares the performances. The reason
why five models are run is to guarantee, to a certain extent, the robustness of the
dataset. If four out of five models show a performance no better than random, it
can be interpreted as the dataset not containing any distinctive patterns that might
be of interest and that that one model probably modeled data noise as predictive
patterns.
HypE compares the different models’ performances based on the area under the
receiver operating characteristic (ROC) curve (AUC) [82]. To simply put it, ROC is
a mechanism for visualizing the performance of a binary classifier and AUC is an
instrument for summarizing a binary classifier performance.
A binary classifier is one which output can be only one out of two possible classes,
meaning that any given input can be classified as either class A or class B. Regarding
misclassifications, there are two cases to account for: the true positives and true
negatives, which Figure 31 shows how to calculate. Additionally, it also shows some of
the most common performance metrics usually computed, namely accuracy, precision
and recall, and the F-score.
ROC graphs are two-dimensional graphs that are built from the true positive
(TP) and false positive (FP) rates [83]. Specifically, the ROC represents the FP in
X axis and the TP on the Y axis, thus illustrating the tradeoff between the true
positives and true negatives. Figure 31 shows how to calculate these rates and how
does a ROC plot looks like.
Simply stated, AUC corresponds to the area percentage of the ROC plot that
is under its curve [85]. A perfect model would have an AUC of 1, as the ROC plot
would be a curve that followed the upper left side of the plot, and a model no better
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Figure 31: From left to right: (a) binary classifier confusion matrix detailed; (b) several
model performance metrics computed from the confusion matrix; (c) example of ROC curve
[84].
than random would have an AUC of 0.5, as the ROC would be close to the diagonal
of the plot, which is usually plotted for visual reference in Figure 31.
AUC was the performance metric of choice to compare the models’ performances,
for each dataset being analyzed, mainly do to the fact that it has shown to be a
better metric than accuracy, specially when considering unbalanced datasets, meaning
datasets in which one class is (much) more common than the other [86]. Given the
nature of data used for the development, ICU data, it is expected than some datasets
will be indeed unbalanced, for example a dataset regarding a medical condition that
is highly deadly.
As it was mentioned before, each dataset is modeled five times, each one with an
independent estimation of the C parameter value. Afterwards, the AUC of all runs
are compared, as Figure 32 exemplifies. In the prototype implemented, a dataset is
considered as containing potentially interesting patterns if the model shows, in at
least three out of the five runs, an AUC of value superior of 0.70. This threshold was
essentially an educated guess, based on some different subsets of the MIMIC data.
5.4 Hypothesis Embodiment
In the successful case that the data is considered to have interesting predictive
patterns, according to the defined thresholds, the next and final step is to somehow
show those patterns to the user. The process of presenting them in a human-friendly
format corresponds to the embodiment of the hypothesis phase. This phase of HypE
is then responsible for representing the patterns found in a way that the user can
effortlessly understand them. For example, complex hypotheses involving nested
item-value patterns found would be presented in a condensed form such as “in a
certain dataset, patients that show an accentuated decrease of hemoglobin, and then
an increase of leukocyte values, are much more likely to die”.
Considering the intended easy-to-interpret output, decision trees seemed to be a
very clear way to quickly understand such patterns and identify different possible
scenarios to look out for, and their correspondent outcome (death or surviving) rates,
as they have been shown to perform very well in clinical scenarios [87].
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Figure 32: Left picture: parameter tuning search plot - how different values of C influence
the overall model performance. Right picture: the model performance values, with the best
C parameter estimation, throughout five runs.
Figure 33 exemplifies how the output was implemented in the prototype, and
also details the visualization components.
N patients of 
outcome 0
The most common 
outcome variable in the 
set represented by the 
node
N patients of 
outcome 1
Dataset portion size
(a) Tree node explained
(1)Feature-regarding-laboratory-item
(2) >, <, <=, >=, =
(3) slope threshold 
(b) Tree splits description 
explained
(c) Example of a decision tree embodying an hypothesis dataset extracted from HypE. 
Figure 33: HypE’s prototype output visualization by decision trees, for a real MIMIC subset
of patients diagnosed with "Protein-calorie malnutrition".
In the prototype, the algorithm chosen to build the DT was the CART [88].
CART is a common implementation of binary decision trees, which means that each
node is split into two branches, making the resulting trees easy to understand. In the
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prototype, two parameters of CART were specifically defined: the tree complexity
parameter and its maximum accepted depth.
In a nutshell, the complexity parameter of a decision tree greatly influences the
splits generated, as it enforces that all generated splits must decrease the overall
classification error by at least its value. In other words, it can be seen as a built-in
pruning that avoids splitting the data into sets that will bring the resulting tree no
performance advantage. HypE’s uses a complexity parameter of value 0.02, which
means that each split should increase the DT’s performance in at least 2%.
The self-explanatory parameter for the maximum accepted depth of the tree,
limits the amount of node splits allowed. The deeper the trees, the harder to interpret
the results, which is why HypE is limited to trees with three levels of nodes (the root
counts as level zero).
The decision trees outputed, however, differ from the most common used DT
trees, given the nature of the data being used to build them. Note that the feature
data consists on the slope between any two points in time, which means that the tree
split values will be slopes as well. Having acknowledged this, the interpretation is
not as easy as checking some patient current value for some laboratory measurement
and it does raise the question of how to categorize the slopes into natural language
conclusions. For example, starting from what slope value is an increase considered
"significant" as in "item A showed a significant decrease".
Nevertheless, it is now worth reminding that the contribution of this system is
not in the use of certain methods for certain tasks, but in the pipeline of operations
that allow for the identification of data patterns by automatic analyzing diverse
raw laboratory data. Hence, the implemented prototype uses decision trees (DT)
algorithm for generating an easy-to-read output, but any other computational method
or visualization tool can be used.
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6 Results
Given the nature of HypE’s goal to automatic mine data sets in search for biomedical
relevant phenomena, reporting results requires manual selection of examples, specially
if we want to present cases in which no hypothesis was found.
Considering that the system aims at precisely directing the user’s attention to
datasets that might have been missed otherwise, there is no metric that can be used
to evaluate the performance of the system implemented. Instead, some examples of
what HypE outputted will be presented.
6.1 Diagnoses Subsets
In this prototype, all subsets analyzed were diagnosis-based, by which we mean that
they were sliced out of the original data, by a certain diagnosis’s patients cohort,
regardless of any additional diagnosis. For instance, one diagnosis present in the
MIMIC database is chronic diastolic heart failure (ICD9-Code 42832 ), and so the
correspondent subset would consist on all patients associated with this diagnosis.
There are two essential issues to consider when modeling data in HypE: the
amount of the data being analyzed, at once, and the balance of the output variable.
Generically speaking, bigger sets of data are expected to train better predictive
models which extrapolates that HypE is more likely to find interesting phenomena
the bigger the sets are. For instance, some diagnosis are so rare that only a few
cases are reported in MIMIC database, making any predictive analysis meaningless.
Figure 34 shows the subset sizes distribution; the figure is spitted into three groups
because the amount of diagnosis that had less than 20 patients is much bigger than
all the rest. For example, drug-related admissions are quite rare in MIMIC, even
more so because there are over 10 different ICD9 code for different drug type and
frequency use.
Figure 34: Density distribution plot of the size of all available subsets, per "cluster": dataset
associated with less than 100 patients (left), from 101 to 999 patients (middle), 1000 patients
or more(right).
With respect to the survival ratio, the amount of surviving versus death patients
within a data subset, it is of great importance as it is the outcome variable considered
in the prototype that was tested. Too unbalanced subsets are not good for modeling,
as the models are likely to be biased once the data clearly has much more of one
outcome class than the other. Figure 35 shows that are many diagnosis sets with a
balanced outcome ratio, although it does show two high density areas in the extreme
of the plot, which represent both the most and least lethal diagnosis.
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Figure 35: Density distribution of the outcome ratio of all datasets. Red color represents a
low death ration (more subjects alive), and the blue a high death ratio (more subjects dead).
6.2 Hypothesis extracted
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Figure 36: MIMIC diagnosis with most patients associated, and the correspondent outcome
(alive/dead) ratio. The diagnosis descriptions correspond to the official ICD9 codes short
description.
This section details a few diverse examples that show both the potential and limi-
tations of HypE, mainly focusing on the output embodiment. It is worth mentioning
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that as no medical physicians were involved in the development of this project, there
was no scientific crosschecking of research with the results that are presented in this
chapter.
Figure 36 shows the most common diagnostics in the data, as well as the corre-
spondent survival ratios. As it can be seen, "unspecified essential hypertension" is
undoubtedly the biggest diagnostic subset and shows a good survival ratio, but the
diagnosis itself states its non-specificity, which can make any hypothesis found even
harder to interpret as a promising. Hence, choosing clearer diagnostic subsets eases
the result analysis, as the results can be, for example, crossed with that diagnosis
related research and verify if the hypotheses make any biomedical sense, at all. Out
of the biggest sets in the data, we did analyze the sets of Coronary atherosclerosis of
native coronary artery and arterial fibrillation, but unfortunately no hypothesis were
found. A plausible reason for this might be these sets heterogeneity, in regards to
other diagnosis the patients may have, for example.
With slightly less patients, we present the results for the mitral valve disorder,
depressive disorder and bacteremia cohorts. Figure 37 details the patient sample size
during the previously described feature engineering phase, for all three diagnoses
sets that were analyzed, and which results are presented in the next sections.
Diagnosis description
(ICD9 short description)
MIMIC
(#patients)
After data 
subsetting
(#patients)
After feature 
selection
(#patients)
Mitral valve disorder 2651 1596 1057
Depressive disorder 
NEC 2926 1408 868
Bacteremia 1321 940 696
Figure 37: Patient sample size (how many patients), in the original MIMIC database, after
the data sub-setting (time-restriction requirements), and in the feature data (final set used
for analysis).
The reason for choosing these sets was essentially the different nature of the
diagnosis themselves. In non-professional terms, mitral valve disease is when the
mitral valve (located between the left heart chambers) does not work properly. A
quick search online shows evidence that complications from the disease are known
causes for the patient to end up in an ICU. On the other hand, depressive disorder is
a mental disorder, which, by itself, is unlikely to be the primal reason for the patient
to be admitted into an ICU, but rather likely to be a second diagnosis. Finally,
bacteremia is, in short, the presence of bacteria in blood, which can lead to sepsis and
death. Because a patient can contract bacteremia within hospital, i.e. during their
hospital stay, it was considered of interesting to look into the extracted hypothesis.
6.2.1 Mitral Valve Disorder
Mitral valve disorder has been showed to be associated with atrial fibrillation, which
is one of the main diagnosis present in the database, as Figure 36 shows. However,
in this case, HypE did find an hypothesis worth outputting.
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The resulting DT is an example of the shortest possible outputted, with one node
level only. Both tree leafs show the presence of both outcomes, which is not ideal,
even though excepted, specially with such a non-deep tree.
Figure 38: Decision trees embodying the hypotheses identified in the sets of the mitral valve
diagnose.
6.2.2 Depressive disorder
Unlikely the previous example, the depressive disorder tree„ has more node splits,
which usually means that the leafs are more homogeneous, outcome wise, even though
it is not exactly the case here.
Figure 39: Decision trees embodying the hypotheses identified in the set of depressive
disorders diagnose.
Considering the database used consists on patients admitted into intensive care
units, it is safe to say that mental disorders, such as depression, are unlikely to be
the main reason for the hospital stay. Instead, it is highly likely that depression is
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just another diagnosis that the patient is associated with. For instance, depression
can be a result of a long illness, or for example given the prospect of near death
[89]. Thus, the cohort data used in this example is most likely highly heterogeneous,
specially regarding the conditions that may have lead to the patients extreme health
conditions and consequent admission into an ICU.
6.2.3 Bacteremia
As it was mentioned before, bacteremia is a condition that can be contracted during
hospital stay, and lead to sepsis and even death. In-hospital contracted conditions are
oftentimes studied and tools like HypE could be of great use to try to find patterns of
infection spreading that may have not yet been identified by physicians. Thus, there
was a certain scientific curiosity to see what Hype would output with such dataset.
Surprisingly, some hypothesis were indeed outputted. Figure 40 presents the
results for the dataset of diagnosis bacteremia. In short, bacteremia refers to the
presence of bacteria in blood. Interestingly, looking at the outputted tree, we have
blood components which evolution is commonly tracked in a case of infections,
in general, and bicarbonate can be used in the treatment of bacteremia, as it is
mentioned in [90].
Figure 40: Decision trees embodying the hypotheses identified in the sets of bacteremia.
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7 Discussion
The HypE system aimed at developing a data mining tool capable of automatically
mine big biomedical datasets, from different angles (meaning datasets), and identify
potentially interesting data patterns that seemed to be worth looking into. As
such, HypE was envisaged to be a clinical decision support system, or at least to be
integrated into one.
The implemented prototype was a partial implementation of the whole system,
as the main goal of this project was HypE’s proof of concept. As such, operations
like sub-setting the data for analysis, how that data is analyzed, and how the
results are visualized are currently limited to the implementation choices we’ve made.
Nevertheless, as it was mentioned before, the contribution of this work is in the
pipeline, and not the specific methods or tools used for operation A or B.
Figure 41 illustrates the prototype complete pipeline, and details the implemen-
tations choices for each step.
Figure 41: The prototype pipeline, and specifications of operations and implementation
choices.
The stage designated as feature engineering corresponds to a sequence of steps
that manipulates the data into the format needed for the predictive analysis. Cross
checking the results with the prototype pipeline, it is clear that the feature engineering
phase leads to a reduction of the data available for analysis, which was expected,
given the irregular nature of clinical data, time-wise, i.e., some patients might have
several laboratory items being tracked through time while others in a similar medical
condition might not have those same data.
Furthermore, the choice of support vector machines algorithm for the predictive
analysis also involves sacrificing some more data, given the version used does not
support missing values. The strategy used for this step was developed specifically for
this project, and its goal was to diminish the amount of samples to be dropped from
the dataset, and prioritizing the exclusion of features that were "too" sparse, according
to the defined threshold. The alternative considered during the development was to
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estimate the missing data values, by some imputation method, which would mean
that data being analyzed would not be entirely "real".
Regarding the serialization of the time-series data, one conceptual change that
could be changed would be to consider different admissions, as different "samples".
For example, a patient that has been twice in the ICU, long enough for it to have
data meeting the requirements for analysis, could be split into two different samples,
for example.
Lastly, the outputted decision trees unveiled a problem with using slope values
as features, which is the interpretation of the actual output. In fact, the hypothesis
embodiment step would likely be Achilles heel of the prototype. One important aim
of the system was to package the medical phenomena in a way that would be easy
to interpret, and that is not the case with "slope" values. In theory, it made sense to
think of the time evolution of an item as a straight line and that the slope would
indicate whether it decrease, increased or didn’t change. However, in practice, the
DT splits are conditions such as "slope higher that 0.34", which include anything
from so very minimal increase change to very rapid increase. Thus, it is acceptable
to say that DT might not be the best choices for outputting this type of information.
One strategy could be to firstly convert the continuous slope values into categories,
like "slight increase" or "rapid increase" and then use some other output format to
clearly represent such pattern.
Still in the topic of the output interpretative value, one issue that was highlighted
by the DT examples was that the slopes do not contain any information regarding
whether they represent values that were outside the recommended value range. In
other words, it might be important to understand if the increase or decrease of, for
example, hemoglobin, is happening within the clinical references, because if not, such
variation might have a different meaning. Therefore, finding a strategy to include
this information in the analyzes would be of great usefulness.
7.1 System limitations
As expected with any proof of concept project, the system does have several limitations,
regarding the pipeline itself. This section describes them and how they could be
overcome in the future.
Regarding the data subsetting, the diagnosis-based approach was a simple method
that would allow us to divide the database into many different sets, which was an
advantage in the development phase. However, in future versions of the system,
other logic for data splitting could be used. For instance, ICD9 has many different
codes that relate to similar scenarios, of example cocaine dependence, unspecified
(ICD9 code: 304.20), cocaine dependence, continuous (ICD9 code: 304.21), cocaine
dependence, episodic (ICD9 code: 304.22), cocaine dependence, in remission (ICD9
code: 304.23). It could be interesting to merge them into one single cohort before
analyzing it for medical phenomena, or maybe filter some other cohorts by age, or
other conditions.
The choice of supporting only binary target variables was mainly to match the
intended output, as the decision trees are used to visualize binary numerical data
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only. Nevertheless, even with such a simple output type scenario, more complex
cohorts could be already analyzed, for example, considering other diagnosis, or specific
condition, as output, in which case an extra layer of analysis would be needed, in
order to consider the multiple comparisons problem[91].
Still concerning the data subsetting, maybe the biggest limitation of HypE, as of
now, is the exclusive support of numerical data. We do believe that categorical data
may contain lots of relevant information, maybe more so that numerical data, which
is usually what is the base of EHR data analysis, but it would require heavier data
processing and different choices for the predictive analysis algorithms.
Technically, HypE was implemented in R[92], making use of several different
packages, for particular operations, and it is completely functional on any data that
is loaded into the system.
However, the development of the prototype did not take into consideration issues
like performance and efficiency, which means that the process from input to output
might take longer than ideal. Parallelization was not considered, which means
that the pipeline runs once at a time, not allowing for multiple datasets analyses.
Nonetheless, making it parallel-proof would not require major changes.
7.2 Future Work
The biggest change we would recommend going forward would likely be the pro-
gramming language, as a system with the characteristics and goals of HypE would
certainly benefit from fast performance, of which R is not a particular example of.
In the case of wanting to actually test out HypE in a real world scenario, the
biggest challenge would very likely be whether or not to consider it as a standalone
tool, or integrate it into some other system. In the first scenario, and considering the
current performance was not an issue, the prototype as it is could definitely mine any
database, requiring however the data subsetting process to be customized for that
database. In the second scenario, it would anyhow depend upon the integration of it
into another existent system, which is a talk of which the complexity of we cannot
access without knowing the system in question.
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8 Conclusion
First of all, it is important to recap what HypE’s purpose is and what the expectations
of this proof of concept project were.
The hypothesis engine was a system that was envisaged to automatically mine
electronic health records (EHR) data and output cohorts that seemed to have some
patterns that could make researches or physicians want to look into.
The motivation essentially came from the belief that patients with certain diag-
noses might have distinct indications of either survival or death, medically-wise. As
such, in those case, it would make theoretical sense to expect HypE to find hypothesis
that would be easily associated with the diagnoses in research regarding precisely
those conditions.
It is important to understand that HypE does not intend to replace medical
research or even to find unknown groundbreaking connections/correlations/causality
within conditions, although theoretically it could. Instead, HypE wants to support
the medical staff by signalizing biomedical phenomena, as soon as it is possible,
ideally before the doctor himself realizes it.
Naturally, the developed prototype was a somewhat limited version of what we
believe a system like HypE can do, which has necessarily adjusted our expectations.
On one hand, the data subsets analyzed were diagnosis-based, which makes sense on
paper, but when considering an EHR database, and the fact that there are lots of
different ICD9 codes for similar diagnosis, would make lots of subsets too short for
analysis when they could be analyzed as a single cohort.
On the other hand, the publicly available database used as a data source, MIMIC,
consists on data from patients admitted into ICU units. From the clinical perspective,
it narrows down the potential interpretation of whatever hypothesis might be found,
considering these are patients in extreme health conditions. In other words, the
additional fact that all the data comes from subjects in severe condition is likely to
make the data noisy, to some extent, which is why the results were not expected to
be in a certain way.
Looking at the results, we do believe that automatically analyze big datasets
in search for cohorts of data the show interesting characteristics is definitely, not
only valuable, but possible. Tools like HypE can hint to things that might be missed
otherwise, and could be used in cooperative or research environments.
Since the beginning of this project, interesting research has been published
regarding the mining on EHR data, and using MIMIC database as well, and exploring
more recent ML architectures, such deep learning, which has achieved very promising
results [45, 93].
Biomedical data is as messy as it is rich in information, which is why translating
such information into knowledge is of great value, as useful data is much more worthy
than non useful data.
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